[nanoPost] Nanoparticulate formulations for the pharmaceutical and healthcare industries

Company UK

The company use novel reactor technology to develop and manufacture nanoparticulate formulations for the pharmaceutical and healthcare industries

The nano-particle forming process employed does not rely solely on extensive and repeated mechanical shearing of pharmaceutical ingredients and can rapidly generate nano-particles. Furthermore, unlike other available technologies, The company's processes include in-line de-agglomeration, dispersion and homogenisation of the Active Pharmaceutical Ingredients (APIs). This provides greater control over particle size and size distribution with potential benefits in enhancing and controlling drug bioavailability, efficacy and toxicity.

The companys' competitive advantages are therefore:

- Reduced production time and costs through rapid nano-particle generation and additional in-line processing.
- Improved process environment control - single-step continuous process.
- Improved control of particle size and distribution.
- Fewer surface defects/amorphous i.e. cleaner, more crystalline surface.
- Significantly expand the range of drugs that can be subjected to nano-processing.